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may face additional challenges during a pan-
demic, including increased vulnerability and
transmissibility from overcrowded living con-
ditions, reliance on mass transportation, and
limited access to health care.17
Although there have been some previous
efforts to vaccinate high-risk populations, few
were community-based.18 Community-based
programs that contributed to increased vacci-
nation coverage have included vaccination at
syringe exchange sites,19 an immunization
“blitz” in a neighborhood with widespread
injection drug use,20 interventions in religion-
based neighborhood health centers, and pub-
lic service announcements and mailings tar-
geted to racial/ethnic minority Medicaid
populations.21,22 Interventions in medical set-
tings have included components such as
standing orders,23,24 mailings,25–27 educa-
tion,28–30 targeted advertising,31 and visiting
nurse programs.32 Unfortunately, these efforts
may have had little impact on hard-to-reach
populations, because members of these groups
are less likely to access routine health care.
In December 2003, members of the
Harlem Community and Academic Partner-
ship,33 comprised of representatives from
community and academic organizations com-
mitted to implementing interventions by using
a community-based participatory research
(CBPR) approach, formed an intervention
working group to address challenges in vacci-
nating local hard-to-reach populations. Com-
munity-based participatory research is a col-
laborative process among researchers and
community members that emphasizes build-
ing trust, equitable power sharing, capacity
building, and long-term commitment from
all involved in the research process.34–36
The intervention working group, which was
National guidelines recommend annual in-
fluenza vaccination for high-risk groups—
specifically, persons 50 years and older and
persons of any age with chronic medical con-
ditions and their household contacts.1 De-
spite these guidelines and the patent benefits
of influenza vaccination—including reduc-
tions in influenza-related morbidity and mor-
tality, attendant health care costs, and pro-
ductivity losses2—vaccination rates among
adults in the United States remain lower
than recommended levels, especially among
elderly with high-risk conditions and racial/
ethnic minorities.1,3–5
Although data are sparse, influenza vacci-
nation rates are particularly low among mar-
ginalized hard-to-reach urban populations
such as substance abusers, undocumented
immigrants, and homebound elderly.6 During
the 2004–2005 influenza vaccine shortage,
the vaccination rate was 21% among hard-
to-reach populations in designated priority
groups for vaccination, compared with esti-
mates of 42% among designated priority
groups in the general population during this
same period.7 Members of these hard-to-reach
groups are less likely to access routine health
care or have a health care provider.8–10 Low
vaccination rates combined with risk factors
and barriers to accessing health care place
hard-to-reach populations at particularly high
risk for influenza and attendant morbidity.
Additionally, the need for improvements
in annual influenza coverage is coupled with
recent concern for the potential of a human
influenza pandemic.11,12 Unvaccinated per-
sons within the larger population may prop-
agate disease, particularly in the event of a
pandemic.2,13 Consequently, public health
officials face mounting pressure to vaccinate
persons in all risk groups and to do so in a
brief period of time.14–16 Members of disad-
vantaged, urban, multiethnic communities
Objectives. We sought to determine whether the work of a community-based
participatory research partnership increased interest in influenza vaccination
among hard-to-reach individuals in urban settings.
Methods. A partnership of researchers and community members carried out
interventions for increasing acceptance of influenza vaccination in disadvantaged
urban neighborhoods, focusing on hard-to-reach populations (e.g., substance
abusers, immigrants, elderly, sex workers, and homeless persons) in East Harlem
and the Bronx in New York City. Activities targeted the individual, community or-
ganization, and neighborhood levels and included dissemination of information,
presentations at meetings, and provision of street-based and door-to-door vacci-
nation during 2 influenza vaccine seasons. Participants were recruited via multi-
ple modalities. Multivariable analyses were performed to compare interest in re-
ceiving vaccination pre- and postintervention.
Results. There was increased interest in receiving the influenza vaccine postin-
tervention (P<.01). Being a member of a hard-to-reach population (P=.03), having
ever received an influenza vaccine (P<.01), and being in a priority group for vacci-
nation (P<.01) were also associated with greater interest in receiving the vaccine.
Conclusions. Targeting underserved neighborhoods through a multilevel com-
munity-based participatory research intervention significantly increased interest
in influenza vaccination, particularly among hard-to-reach populations. Such
interventions hold promise for increasing vaccination rates annually and in
pandemic situations. (Am J Public Health. 2008;98:1314–1321. doi:10.2105/
AJPH.2007.115986)
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comprised of members representing commu-
nity residents, community-based organizations
(CBOs), academic institutions, and the local
health department, met regularly throughout
the project to develop the research agenda
and study design and to guide project imple-
mentation and evaluation. Guided by the
Harlem Community and Academic Partner-
ship principles of collaboration, the working
group adopted a participatory approach to
decisionmaking processes. A multilevel study
design was chosen to address individual, so-
cial, and contextual factors related to access
to, and acceptance of, the influenza vaccine
among hard-to-reach populations.37,38 The
working group developed methods to target
intervention activities to 3 levels: neighbor-
hood, CBO, and individual.
The overall goal of the Project VIVA
(Venue-Intensive Vaccines for Adults) inter-
vention was to develop, implement, and as-
sess a rapid-vaccination protocol for hard-to-
reach populations that would increase interest
in vaccination, provide free vaccination dur-
ing 2 influenza seasons, and establish a
model for the rapid vaccination of individuals
that could be generalizable to other urban
areas. We report the results of Project VIVA,
including pre–post surveys in the 8 target
areas within East Harlem and the Bronx,
New York City, that evaluated whether inter-




Intervention activities were conducted in 8
racially and ethnically diverse and economi-
cally disadvantaged locations in East Harlem
and the Bronx. These 3 neighborhood areas
in East Harlem and 5 in the Bronx were 6 to 8
blocks in size and were chosen through a
participatory decisionmaking process with
members of the intervention working group.
The neighborhoods were also chosen on the
basis of existing partnerships with CBOs in
the area and because the neighborhoods in-
cluded areas in which hard-to-reach popula-
tions were known to congregate.6,39
Although there is no uniform definition of
hard-to-reach populations,40–43 populations of
interest included substance abusers, possible
undocumented immigrants, homeless per-
sons, commercial sex workers, and persons
65 years or older, including the homebound
elderly.
Study Design
The intervention project was structured in
5 sequential phases: enumeration, vaccine
shortage, pilot vaccination, rapid vaccination,
and results dissemination (referred to as
phases 1 through 5). In phase 1 (February–
October 2004) staff conducted outreach to
community members, organizations, and lead-
ers; estimated the size of hard-to-reach popu-
lations in the target neighborhoods; and com-
pleted surveys to examine barriers to
vaccination.6 Results from these surveys
helped guide the intervention strategy. The
size of hard-to-reach populations was esti-
mated through several methods, including
venue-based and door-to-door sampling.
Venue-based sampling resulted in the highest
estimates of homeless persons, sex workers,
and substance abusers; door-to-door sam-
pling yielded the highest estimates of el-
derly and immigrants.
The flu vaccine shortage of 2004–2005
caused a delay in project activities, postpon-
ing the pilot vaccination phase until more vac-
cine was procured. From October to Decem-
ber 2004 (phase 2), outreach workers
surveyed community members to assess
awareness of the shortage and access to the
vaccine.7 Beginning in January 2005, phases
3 and 4 were implemented with a crossover
design: 4 neighborhoods chosen at random
received the pilot vaccination intervention to
assess acceptance of vaccination
(January–March 2005), whereas the remain-
ing 4 neighborhoods received the rapid vacci-
nation intervention later that year (Septem-
ber–October 2005). The rapid vaccination
effort was used to develop a protocol for vac-
cinating hard-to-reach populations in the
event of an influenza pandemic or other
emergency situation.44
During phase 3, a team of 4 outreach work-
ers and 1 clinician offered vaccination door-
to-door in apartment buildings over 8 weeks.
Phase 4 was designed to scale up, by aiming to
vaccinate 1500 individuals in the remaining
4 neighborhood areas simultaneously during
10 working days.44 Following 6 weeks of
outreach efforts, 4 teams of 2 nurses and 4
outreach workers offered vaccination door-to-
door, at street-based venues, and at CBOs.
Phase 5 focused on generalization and dis-
semination of the most promising elements of
the intervention. We developed a project Web
site (http://www.projectviva.org) and spon-
sored an experts meeting to generate strate-
gies to improve immunization rates among
hard-to-reach populations.45 Project staff also
presented findings at community meetings,
CBOs, and scientific conferences.
Data Collection
Community residents were sampled through
street-based intercepts in 16 venues selected
as areas of high traffic in each of the 8 neigh-
borhood areas (2 venues per neighbor-
hood),6,39 and door-to-door assessments of a
random sample of residences in each of the 8
areas. Persons were eligible to participate if
they were 18 years or older, spoke English or
Spanish, and provided informed consent. In
street-based intercepts, participants were first
approached and asked if they would be willing
to complete a survey. In door-to-door inter-
views, teams of interviewers approached per-
sons at the doorway of their home and invited
them to participate. After participants provided
verbal informed consent, outreach workers
administered a brief, anonymous survey. The
survey assessed self-reported sociodemo-
graphic characteristics, social marginalization
indicators including substance abuse and com-
mercial sex work, access to health care and
general health, vaccination history, and trust of
government and social agencies. The outcome
measure, interest in vaccination, was assessed
in the survey through the question, “Are you
interested in taking a vaccine against flu?”
Participants were eligible to receive the
vaccine following survey administration if
they provided written informed consent, re-
ported no previous adverse reactions to a vac-
cine, reported no allergy to eggs, had not
been previously diagnosed with Guillain-
Barré syndrome, were older than 19 years,
had not already received the vaccine for
that flu vaccine season, and were not preg-
nant. Participants 19 years and older were eli-
gible for vaccination because state reporting
requirements mandated that younger persons
report vaccinations, rendering the process
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confidential but not anonymous. Additionally,
although pregnancy is not a contraindication
for influenza vaccination, working group mem-
bers decided that vaccination of pregnant
women would not be well received in our tar-
get communities.
Intervention Activities
Intervention activities were tailored to the
neighborhood, community organization, and in-
dividual level within the 8 neighborhood areas
from February 2004 through January 2007.
At the neighborhood level, outreach work-
ers distributed project informational flyers, a
comic strip outlining common vaccination
myths, and locations of free vaccine clinics to
community residents via door-to-door and
street-based venues. Materials were dissemi-
nated over the course of the project to raise
awareness and visibility and to increase inter-
est in vaccination. A project phone number
was included on all materials and calls were
answered during business hours.
At the community organization level, staff
members presented information about the
project at local community board meetings
and CBOs. Presentations informed commu-
nity members about future activities and gath-
ered feedback on project methods and results.
At the individual level, nurses and physicians
provided vaccination to eligible participants
during the vaccination phases (phases 3 and 4).
Data Analysis
Intervention activities were tabulated by
intervention level and phase. Additionally, to
compare characteristics and behaviors that
were associated with interest in receiving in-
fluenza vaccination at the time of survey, fre-
quency and proportions were calculated for
each variable of interest. Variables were se-
lected on the basis of a priori knowledge and
included being a member of a hard-to-reach
population, prior receipt of an influenza vac-
cine, being medically contraindicated for vac-
cination, date surveyed, and being medically
indicated for vaccination, or in a CDC-desig-
nated priority group for vaccination. Persons
designated as priority groups for vaccination
were persons 65 years or older, and adults
who had heart disease, kidney disease, dia-
betes, HIV/AIDS, asthma, and other chronic
conditions. Differences at the bivariable level
were tested with the Pearson χ2 test except
for when low sample sizes made the use of
Fisher exact test more appropriate.
Three multivariate logistic regression
models were developed to assess possible
correlates of interest in receiving influenza
vaccination. Groups modeled included the
preintervention sample (phases 1–2), the
postintervention sample (phases 3–4), and
the combined pre- and postintervention sam-
ples (phases 1–4). Additionally, interest in
vaccination was also modeled by neighbor-
hood and hard-to-reach population groups.
In the preintervention period, outreach efforts
raised awareness and increased visibility of
the vaccination effort. The postintervention
period, in addition to the pilot and rapid
vaccination efforts, also included a signifi-
cant outreach component. Generalized esti-
mating equations were used to account for in-
traneighborhood correlations. From the final
models, odds ratios (ORs) and corresponding
95% confidence intervals (CIs) and P values
were derived. All analyses were performed
with SAS software, version 8 (SAS Institute
Inc, Cary, North Carolina).
RESULTS
Among 6826 participants surveyed from
February to October 2005 (n=3744 prein-
tervention and n=3082 postintervention) the
mean age was 41 years, 60% were women,
72% were Hispanic, and 68% reported an
annual income of $9600 or less. Interest in
vaccination significantly increased following
intervention (80% preintervention to 94%
postintervention; P<.01).
Overall, 37% of participants were members
of 1 or more hard-to-reach populations, includ-
ing substance users (18%), sex workers (2%),
persons 65 years or older (7%), undocumented
immigrants (16%), and homeless persons (6%).
Demographic characteristics differed by study
phase. Participants surveyed before the interven-
tion were more likely to be younger, female, and
Black, whereas participants surveyed after the
intervention were more likely to be Hispanic (all
P<.01). Participants were more likely to be sam-
pled door-to-door if they were older, Hispanic/
Latino, and a member of a hard-to-reach popula-
tion, and more likely to be sampled from street-
based settings if they were women (all P<.01).
The number of missing values ranged from 24
to 282 (<1%–4%) for all variables.
Intervention Activities
Table 1 presents activities implemented at
each intervention level and within each proj-
ect phase. At the neighborhood level, 28323
items, including flyers, comic strips, and in-
formational pamphlets, were distributed to
passersby and neighborhood residents in
phase 1. Almost 20000 items were dissemi-
nated in phase 2, and during phases 3 and 4,
41490 items were handed out. During the
final phase of the project, staff disseminated
24000 flyers that noted locations of free
vaccine clinics. At the community organiza-
tion level, 19 presentations were given to
local community boards and organizations
during phase 1, and 16 presentations were
conducted during the remainder of the proj-
ect. Finally, 566 and 1648 participants were
vaccinated in phases 3 and 4, respectively.
TABLE 1—Influenza Vaccination Intervention Outreach Activities in 8 Neighborhood Areas,
by Level: Project VIVA, East Harlem and the Bronx, New York City, 2004–2007
Neighborhood Community Organization Individual 
Level (Materials Level (Meetings, Level 
Phase Disseminateda) Presentations) (Vaccination)
Enumeration (Feb–Oct 2004) 28 323 19 . . .
Vaccine shortage (Oct–Dec 2004) 19 748 3 . . .
Pilot vaccination (Jan–Mar 2005) 8 489 0 566
Rapid vaccination (Aug–Oct 2005) 33 001 5 1 648
Results dissemination (Jan 2006–Jan 2007) 24 000 8 . . .
Note. VIVA = Venue-Intensive Vaccines for Adults. Ellipses indicate that the influenza vaccine was not provided during the time
period.
aProject promotional flyers, vaccination myths cartoons, vaccine and influenza information.
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TABLE 2—Correlates of Interest in Influenza Vaccination Among Residents of 8 Neighborhood Areas: 
Project VIVA, East Harlem and the Bronx, New York City, 2004–2005
Preintervention Postintervention
Total Interest in Total Interest in
Sample Vaccination Sample Vaccination
(n = 3744), (n = 3011), AOR (n = 3082), (n = 2882), AOR
% % P (95% CI) P % % P (95% CI) P
Member of any hard-to-reach population .05 .38
No (Ref) 63.4 79.4 1.00 63.6 93.2 1.00
Yes 36.6 82.1 1.28 (1.04, 1.56) .02 36.4 94.0 1.14 (0.84, 1.54) .41
Ever had an influenza vaccine <.01 <.01
No (Ref) 33.3 72.8 1.00 39.3 91.4 1.00
Yes 66.7 84.2 2.23 (1.80, 2.75) <.01 60.7 94.9 2.37 (2.10, 2.68) <.01
Medical contraindication for vaccine <.01 <.01
None (Ref) 92.0 82.4 1.00 97.5 93.9 1.00
Some contraindication 8.0 57.5 0.25 (0.21, 0.29) <.01 2.5 79.2 0.32 (0.20, 0.51) <.01
Medically indicated for vaccination .07 .92
No (Ref) 60.8 79.5 1.00 61.2 93.5 1.00
Yes 39.2 81.9 1.21 (1.07, 1.36) <.01 38.8 93.6 0.99 (0.84, 1.17) .90
Date surveyed .16 <.01
Jan–Mar 17.8 82.5 1.26 (0.94, 1.67) .12 16.8 99.4 0.96 (0.70, 1.31) .77
Apr–Jun 20.6 77.8 0.97 (0.74, 1.27) .84 . . . . . . . . . . . .
Jul–Sept 50.4 80.7 1.07 (0.70, 1.63) .76 12.2 78.8 0.21 (0.12, 0.36) <.01
Oct–Dec (Ref) 11.2 80.6 1.00 70.9 94.6 1.00
Note. VIVA = Venue-Intensive Vaccines for Adults; AOR = adjusted odds ratio; CI = confidence intervals. Surveys were not completed from April through June during the postintervention period.
Phases 1 and 2
Results of bivariable and multivariable cor-
relates of interest in vaccination among the
3744 study participants sampled in East
Harlem and the Bronx during the preinterven-
tion period are presented in Table 2. Overall,
37% of participants were members of a hard-
to-reach population and 67% reported having
received a prior influenza vaccine. In bivari-
able analysis, being a member of a hard-to-
reach population, ever having received an
influenza vaccine, and being medically indi-
cated for vaccination were associated with
greater likelihood of being interested in re-
ceiving the vaccine. Persons who reported a
medical contraindication for immunization
were significantly less likely to be interested
in the vaccine. In multivariable analysis, per-
sons interested in receiving a vaccine were
more likely to be a member of a hard-to-reach
population (adjusted OR [AOR]=1.28), report
prior receipt of a flu shot ever (AOR=2.23),
and be medically indicated for vaccination
(AOR = 1.21) compared with persons
uninterested in the vaccine. Persons who
had already received that year’s influenza
vaccine were counted among those who
were interested in receiving vaccination but
not actually vaccinated. Participants med-
ically contraindicated for vaccination were
less likely to be interested in the vaccine
(AOR = 0.25).
During phase two, 272 participants were
surveyed to assess attitudes and other barri-
ers to vaccination in the target areas during
the 2004–2005 influenza vaccine shortage.
The findings, described in a previous report,
indicated that vaccination rates were substan-
tially lower than the national estimates.7
However, a higher proportion of those who
received vaccination were members of a pri-
ority group for vaccine. There was wide-
spread awareness of the shortage (90%), and
most attributed it to vaccine production prob-
lems.7 Finally, many of those surveyed said
they would be more likely to seek vaccination
in current and subsequent influenza seasons
because of the shortage.
Phases 3 and 4
During phase three, 566 vaccines were ad-
ministered door-to-door in 4 neighborhood
areas. Vaccines were not distributed in CBOs
or street-based settings, because the vaccine
shortage limited the vaccine supply. Almost
half (45%) of doors that were approached
were opened; of those, 27% received the vac-
cine. Half (52%) of those vaccinated were
members of a hard-to-reach population. Dur-
ing the 10-day phase 4, a total of 1648 vac-
cines were administered in the remaining 4
neighborhoods door-to-door, on the street,
and at CBOs. Almost half (45%) of doors ap-
proached were opened and 46% of those
who opened their door received the vaccine.
Members of hard-to-reach populations com-
posed 47% of those who received the vac-
cine. In phases 3 and 4, the most common
reasons for not wanting a vaccine were safety
concerns (26%), fear of needles (22%), not
being in a designated priority group for vacci-
nation (18%), and being medically con-
traindicated for vaccination (6%).
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TABLE 3—Correlates of Interest in Influenza Vaccination Among Residents of 8
Neighborhood Areas During Pre- and Postintervention Sampling: Project VIVA, East Harlem
and the Bronx, New York City, 2004–2005
Interested in 
Total Sample Vaccination AOR
(n = 6826), % (n = 5893), % P (95% CI) P
Surveyed pre- or postintervention <.01
Preintervention (Ref) 54.9 80.4 1.00
Postintervention 45.1 93.5 2.69 (2.17, 3.33) <.01
Member of a hard-to-reach population .04
No (Ref) 63.5 85.7 1.00
Yes 36.5 87.5 1.14 (1.02, 1.27) .03
Ever had an influenza vaccine <.01
No (Ref) 36.0 82.0 1.00
Yes 64.0 88.8 2.20 (1.85, 2.60) <.01
Medical contraindication for vaccination <.01
No (Ref) 94.5 87.8 1.00
Yes 5.5 62.0 0.25 (0.21, 0.30) <.01
Medically indicated for vaccination .12
No (Ref) 60.9 85.8 1.00
Yes 39.1 87.1 1.26 (1.09, 1.46) <.01
Date surveyed <.01
Jan–Mar 17.4 89.9 1.02 (0.60, 1.76) .93
Apr–Jun 11.3 77.8 0.63 (0.36, 1.09) .10
Jul–Sep 33.2 80.4 0.60 (0.35, 1.03) .06
Oct–Dec (Ref) 38.2 92.4 1.00
Note. VIVA = Venue-Intensive Vaccines for Adults; AOR = adjusted odds ratio; CI = confidence interval.
Table 2 shows bivariable and multivariable
correlates of interest in vaccination among
the 3082 participants sampled postinterven-
tion (phases 3–4). In bivariable analysis, only
1 covariate, prior receipt of an influenza vac-
cine, was associated with a greater likelihood
of being interested in receiving vaccination.
Covariates associated with a lower likelihood
of being interested in vaccination were having
a medical contraindication to the vaccine and
the date the participant was surveyed. After
adjustment, the odds of being interested in
vaccination were more than twice as great for
participants reporting prior receipt of an in-
fluenza vaccine (AOR=2.37), whereas partic-
ipants medically contraindicated for vaccina-
tion (AOR=0.32) and persons surveyed from
July to September (AOR=0.21) were less
likely to be interested in vaccination.
Bivariable and multivariable correlates of
interest in receiving the influenza vaccine
among the 6826 participants sampled
during the pre- and postintervention periods
are shown in Table 3. Variables associated
with an increased likelihood of being inter-
ested in receiving the vaccine were being
surveyed postintervention, being a member
of a hard-to-reach population, prior receipt
of an influenza vaccine, and date surveyed.
Persons surveyed from October to Decem-
ber, when most of the vaccine was distrib-
uted, were more likely to be interested in
vaccination (92%), compared with persons
surveyed during the rest of the year (P< .01).
Table 3 shows, after multivariable adjust-
ment, positive associations between being
interested in the vaccine and being sur-
veyed postintervention (AOR = 2.69), being
a member of a hard-to-reach population
(AOR = 1.14), prior receipt of influenza vac-
cination (AOR = 2.20), and being medically
indicated for vaccination (AOR = 1.26). Var-
iables negatively associated with interest in
receiving the vaccine were having a medical
contraindication to the influenza vaccine
(AOR = 0.25) and being surveyed from
April to June in 2004 and 2005
(AOR = 0.63), or from July to September
in 2004 and 2005 (AOR = 0.60).
Interest in vaccination among participants
sampled in the pre- and postintervention peri-
ods was also modeled by neighborhood area
and hard-to-reach population. Interest in
vaccination increased following intervention
in 2 areas in East Harlem and 2 in the Bronx
(P<.01 for all). Hard-to-reach populations
were more likely to be interested in receiving
the vaccine in 2 of the Bronx areas (P=.04
and P<.01, respectively), and ever having re-
ceived a flu vaccination was significantly asso-
ciated with interest in vaccination in all but 1
of the neighborhoods (P<.01 for all). Partici-
pants medically indicated for vaccination
were more likely to be interested in vaccina-
tion in 1 area (P=.03). Among hard-to-reach
populations, undocumented immigrants, sex
workers, and substance users were signifi-
cantly more likely to be interested in vaccina-
tion postintervention (P<.01 for all). Prior
vaccination was significantly associated with
an increased interest in receiving vaccination
among participants 65 years and older,
homeless persons, and substance abusers
(P<.01 for all).
DISCUSSION
Following Project VIVA—a multilevel
community-based intervention aimed at in-
creasing interest in vaccination among hard-
to-reach populations through outreach efforts
and vaccine distribution—persons living in in-
tervention neighborhoods were more inter-
ested in receiving influenza vaccine compared
with before the intervention. Specifically,
members of hard-to-reach populations, per-
sons reporting any prior influenza vaccine,
and persons medically indicated for vaccina-
tion were significantly more likely to be inter-
ested in receiving the vaccine.
The CBPR approach has been shown to be
an effective means to address components of
health promotion in population-level interven-
tion studies.46 The CBPR methods used here,
including the intervention working group–led
intervention planning and implementation,
helped ensure incorporation of community
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priorities, and contributed to our ability to
overcome issues of distrust and to gain access
to members of hard-to-reach populations to de-
liver immunization. Specific factors related to
using a CBPR approach to research, including
outreach activities, and the selection of staff
with personal knowledge of project neighbor-
hoods, ultimately contributed to the success of
the intervention.44 These factors allowed us to
gain access to populations unlikely to report to
a private or government-sponsored health clinic
to receive immunization. Without the expertise
and guidance of the intervention working group
it is unlikely that we would have seen the high
rates of interest in vaccination among study par-
ticipants. Our findings demonstrate the feasibil-
ity of offering vaccination to members of hard-
to-reach populations in nontraditional urban
settings through the use of a CBPR framework.
Vaccination of Hard-to-Reach
Populations
There is a paucity of data related to vacci-
nation rates among hard-to-reach populations,
but reports that do exist show that members
of hard-to-reach populations, when they are
asked, are interested in receiving
vaccination.19,20 In our overall analysis, hard-
to-reach populations were significantly more
likely to be interested in vaccination than
were others. However, hard-to-reach popula-
tions were not significantly more likely than
others to be interested in vaccination after the
intervention. This is probably because of in-
tervention activities increasing interest in vac-
cination among the entire sample, not just
among the hard-to-reach populations. Al-
though Project VIVA offered vaccination, the
impact of the vaccine provision was limited
in duration and scope. We suggest that the
demonstrated increased interest in receiving
vaccination among hard-to-reach populations
was more sustainable and could potentially
affect future health-seeking behaviors. Fur-
ther research will need to assess the sustain-
ability of this increased interest after the ter-
mination of this project.
During the door-to-door vaccine distribu-
tion, less than half of those who opened their
door were subsequently vaccinated. However,
on the street, only those interested in receiv-
ing vaccine were surveyed when approached
by project staff. Although different population
groups were reached via door-to-door sam-
pling compared with street-based sampling,
prioritizing street-based vaccination may
maximize the number of vaccines distributed,
especially in an era of vaccine shortages or
when project resources are limited.
We found that those who had been vacci-
nated in the past were more likely to be inter-
ested in receiving vaccine. This finding is con-
sistent with other studies47–49 and highlights
the importance of promoting access to pri-
mary health care and routine vaccination.
Other studies have also found that increased
access to and use of health care was corre-
lated with higher rates of vaccination.50 Part-
nering with CBOs to deliver health care ser-
vices may hold promise for vaccinating
persons without a regular health care
provider or persons unlikely to report to a
government-sponsored health clinic.
The finding that members of high-risk
groups medically indicated for vaccination were
more likely to be interested in receiving vacci-
nation is consistent with national estimates of
influenza vaccination coverage levels indicating
that 26% of persons aged 18 to 49 years with
high-risk conditions were vaccinated, com-
pared with 17% of persons without high-risk
conditions.1 Our outreach efforts, including
the dissemination of national vaccine guide-
lines, may have contributed to the higher
rates of interest in receiving vaccination
among persons in priority groups.
In pandemic situations, gaining access to
hard-to-reach populations for immunization
could be particularly challenging.44 Unvacci-
nated populations may serve as undetected
reservoirs of infection and key bridge popula-
tions, thereby limiting the effectiveness of
populationwide vaccination efforts. The plan-
ning process for an influenza pandemic
should include the extension of immunization
strategies beyond traditional providers to in-
volve immunization in nontraditional settings,
including CBOs.45
Limitations
There were several limitations to this study.
First, the reliance on self-report of interest in
vaccination may not necessarily translate into
future seeking out of vaccination. Second, this
intervention took place in 8 small underserved
areas in New York City; it is difficult to know
the extent to which these findings are gener-
alizable to other populations in other areas.
Third, our definition of hard-to-reach popula-
tions included all persons 65 years and older,
including homebound and nonhomebound
persons. This definition may have overesti-
mated the number of persons who were truly
hard to reach. The Intervention Working
Group made the decision to target recruit-
ment efforts to the elderly to maximize the
amount of vaccine distributed to those at
highest risk. Fourth, the decision not to vacci-
nate pregnant women may be considered a
limitation resulting from the decisionmaking
process of the working group. Although preg-
nancy is not a contraindication for influenza
vaccination, we respected the concerns raised
by working group members that vaccination
of pregnant women would potentially not be
well-received in our target communities. Fifth,
respondents may have visited a venue more
than once and, thus, may have been surveyed
more than once. Sixth, we estimate that the
majority of participants surveyed in venue-
based settings were community residents;
however, residence was not assessed.
Conclusions
Project VIVA attempted to create an envi-
ronment that was receptive to influenza vacci-
nation in nontraditional settings within our
neighborhood areas. Bypassing the traditional
modes of health care delivery and instead of-
fering vaccination in door-to-door and street-
based settings is a feasible means of accessing
hard-to-reach populations and increasing in-
terest in vaccination. Community-based par-
ticipatory research interventions such as these
may hold promise in increasing vaccination
rates among hard-to-reach populations, espe-
cially in an era of vaccine shortages and
threats of an influenza pandemic.
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